Katarina Nikolić

A perspective on multi‐target drug discovery and design for complex diseases

Rona R. Ramsay, Marija R. Popović-Nikolić, Katarina Nikolić et al. · Clinical and Translational Medicine · 2018 · 701 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +17

Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil–indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease

Óscar M. Bautista‐Aguilera, Gerard Esteban, Irene Bolea et al. · European Journal of Medicinal Chemistry · 2014 · 141 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

<i>N</i>-Methyl-<i>N</i>-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1<i>H</i>-indol-2-yl)methyl)prop-2-yn-1-amine, a New Cholinesterase and Monoamine Oxidase Dual Inhibitor

Óscar M. Bautista‐Aguilera, Abdelouahid Samadi, Mourad Chioua et al. · Journal of Medicinal Chemistry · 2014 · 65 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer&amp;rsquo;s disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids

José Marco-Contelles, Óscar M. Bautista‐Aguilera, Gerard Esteban et al. · Drug Design Development and Therapy · 2014 · 57 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

The oxidoreductase PYROXD1 uses NAD(P)+ as an antioxidant to sustain tRNA ligase activity in pre-tRNA splicing and unfolded protein response

Igor Asanović, Emilia Strandback, Alena Kroupova et al. · Molecular Cell · 2021 · 54 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16